A white-label longevity program supplies the branded technology and administrative layer for a healthy-aging business: a website or app, intake, scheduling, messaging, payments, records workflows, and sometimes laboratory or clinician coordination. It does not transfer authority to diagnose, prescribe, or make health claims. Those functions belong to an appropriately structured clinical entity and independently licensed clinicians.
For an operator, the key question is where the platform’s administrative responsibilities end and the clinical entity’s responsibilities begin. That boundary affects ownership, contracts, marketing, records, state operations, and launch planning.
What does a white-label longevity program include?
A typical program combines a branded digital experience with operational support. The exact package varies, so request a written scope rather than treating “turnkey” as a legal or clinical solution.
Common components include:
- Branded website, patient portal, mobile application, or intake flow
- Appointment scheduling, reminders, video visits, chat, and asynchronous messaging
- Consent, privacy, questionnaire, and onboarding workflows
- Electronic health record or practice-management integrations
- Payments, subscriptions, memberships, invoicing, and administrative billing tools
- Laboratory-order and result-routing workflows
- Clinician credentialing or provider-network coordination
- General wellness education and program content
- Customer service, technical support, and administrative staffing
- CRM, referral, retention, and reporting tools
- Policies, templates, operational playbooks, and vendor coordination
These are platform or administrative services. They should not be described as medical care unless the operating entity is legally structured and authorized to provide it. MDLaunchr is one white-label telehealth infrastructure option in this category; its platform role does not replace state-specific business or clinical review.
What does the operator still own?
The operator generally remains responsible for:
- Brand, market position, target audience, and commercial strategy
- Website, advertising, social content, email, and referral approvals
- States and customer segments targeted
- Management-company structure and agreements
- Payment, subscription, refund, and cancellation processes
- Non-clinical customer service and vendor oversight
- Business reporting and operational service levels
- Review of health, medication, and supervision claims before publication
FTC guidance evaluates the overall net impression created by names, imagery, testimonials, charts, before-and-after content, and scientific references. A disclaimer does not automatically cure a misleading headline or dramatic testimonial.
If a platform handles protected health information for a covered healthcare provider, the parties may need a written HIPAA business associate agreement. HHS states that covered entities engaging business associates must use a written contract requiring safeguards for protected health information and applicable HIPAA obligations.
For recurring memberships, review disclosures, consent, billing, and cancellation procedures. The FTC’s 2024 amendments to its Negative Option Rule are not in force: the Eighth Circuit vacated them on July 8, 2025, and the FTC’s March 11, 2026 advance notice of proposed rulemaking is only a proposal. The Restore Online Shoppers’ Confidence Act still requires online sellers of recurring plans to clearly disclose material terms before collecting billing information, obtain express informed consent before charging, and provide a simple way to stop recurring charges.
Which services require a licensed clinician?
Medical judgment belongs to the clinical entity and its licensed clinicians. Clinician-controlled functions generally include:
- 1Reviewing medical history and performing a clinical assessment.
- 2Determining whether a patient is appropriate for the service.
- 3Diagnosing or considering a differential diagnosis.
- 4Ordering or interpreting medically necessary testing.
- 5Selecting treatment options and considering contraindications.
- 6Prescribing prescription drugs or controlled substances.
- 7Establishing and managing the clinician-patient relationship.
- 8Documenting the medical record.
- 9Providing follow-up and evaluating adverse events.
- 10Deciding when escalation or an in-person examination is needed.
A questionnaire can support clinical review; it should not become an automatic treatment decision. The platform may organize the workflow, but it should not select care for a particular patient.
Platform layer versus clinical layer
| Program area | Platform or management company may supply | Clinical entity or clinician controls |
|---|---|---|
| Brand and website | Design, hosting, analytics, and content workflow | Accuracy of medical content and service descriptions |
| Intake | Forms, consent collection, routing, and reminders | Clinical review and eligibility |
| Scheduling | Calendar and virtual-visit tools | Whether a clinical encounter is appropriate |
| Labs | Ordering workflow and result routing | Medical necessity, interpretation, and follow-up |
| Medication services | Administrative coordination where permitted | Prescribing, contraindications, monitoring, and treatment decisions |
| Patient support | Technical and non-clinical customer service | Clinical questions, adverse events, and escalation |
| Records | Technology and administrative workflows | Clinical documentation, access, and governance |
| Marketing | Campaign execution and brand management | Accuracy of clinical claims and supervision statements |
This table is a planning framework, not a substitute for state-specific advice.
Can a non-doctor own a longevity medical practice?
A non-doctor can own the business and administrative side; who may own the medical practice itself, and control clinical work, is set by state law and entity structure. A nominal medical director does not automatically solve the issue.
In California, the Medical Board states that telehealth remains the practice of medicine, physicians treating patients located in California must be California licensed, and the standard of care is the same as for in-person care. California also restricts non-physician control of specified practice decisions, including clinical staffing, records, referrals, and overall patient care.
In Texas, remote acts affecting diagnosis or treatment of a patient in Texas are treated as the practice of medicine. Texas requires compliance with licensure, scope-of-practice, board rules, and the in-person standard of care. Delegated prescriptive authority has registration and agreement requirements described by the Texas Medical Board.
In Massachusetts, the Board of Registration in Medicine’s June 2020 telemedicine policy states that a preliminary face-to-face encounter is not required before telemedicine care and that the standard of care is the same remotely and in person. Massachusetts still requires physician licensure for practicing medicine and prescribing. Its medical-spa advisory also states that an entity offering ambulatory medical services may require clinic licensure unless wholly owned and controlled by the practitioners providing the services.
These are state examples, not national rules. Requirements vary by state, profession, patient location, entity structure, supervision arrangement, and service type.
What claims can a longevity program make?
Health-related advertising should be truthful, not misleading, and supported by competent and reliable scientific evidence appropriate to the exact claim. High-risk examples include:
- “Slows aging” or “reverses aging” without matching evidence
- “Extends lifespan”
- “Prevents dementia, cancer, diabetes, or cardiovascular disease”
- “Clinically proven” when the evidence does not match the exact service, product, population, and outcome
- Guaranteed weight loss or biomarker improvement
- “FDA-approved longevity program”
- “Doctor-supervised” when clinicians do not evaluate and follow patients
- “Personalized medical treatment” when the service provides only general wellness content
- “Safe for everyone” or “no side effects”
The net impression matters. Images, testimonials, charts, program names, and scientific references can create a disease-treatment or prevention impression even when body copy uses softer wording.
What if the program mentions compounded medication?
FDA states that compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Telehealth companies should not describe a compounded drug as FDA-approved, a generic or equivalent version of an FDA-approved product, clinically proven to produce the same result as an approved product, or supplied by an “FDA-approved” or “FDA-licensed” pharmacy or outsourcing facility.
Review the program’s own advertisements, pharmacy language, clinician-facing templates, landing pages, testimonials, and educational materials it republishes. FDA also states that certain unapproved substances cannot be used in compounding under federal law. This article does not address sourcing, dosing, titration, administration, or patient-use instructions.
What should an operator ask before choosing a platform?
- 1What is the offering? Define whether it is wellness education, coaching, clinical care, or a combination.
- 2Where is the clinical boundary? Identify who evaluates patients, decides eligibility, orders testing, prescribes, documents care, and handles adverse-event escalation.
- 3Which states are involved? Map patient location, clinician licensure, entity ownership, supervision, delegation, clinic, facility, and prescribing requirements.
- 4Who handles data and records? Identify the covered entity, business associate, record custodian, system administrator, retention process, and patient-access workflow.
- 5Which claims are supported? Review headlines, images, testimonials, charts, citations, medication language, and supervision statements.
- 6How does escalation work? Create routes for clinical questions, urgent concerns, adverse events, in-person care, and technical issues.
- 7Who owns each launch task? Assign responsibility for licensing, credentialing, privacy contracting, marketing review, vendor review, billing disclosures, and quality checks.
How is a white-label longevity clinic different from a wellness brand?
A wellness brand can provide education, coaching, community, and habit-support content without claiming to diagnose or treat disease. A white-label longevity clinic or medical program adds clinical services, bringing clinician licensure, records, medical judgment, prescribing rules, and state-specific obligations into the model.
The word “wellness” alone does not determine the legal or advertising characterization. Intake, testing, clinician involvement, prescriptions, and claims can create a medical-treatment or disease-prevention impression.
What should be in the vendor agreement?
The agreement should identify responsibilities rather than relying on labels such as “turnkey” or “full service.” Review:
- Brand ownership and content approval
- Technology, security, uptime, and support
- HIPAA business associate duties where applicable
- Data access, retention, export, and deletion
- Patient communications and clinical escalation
- Clinician credentialing and state coverage
- Clinical protocols and who may change them
- Professional-entity relationships and billing roles
- Laboratory, pharmacy, and vendor coordination
- Advertising review and prohibited claims
- Incident reporting and adverse-event routing
- Subscription disclosures, consent, refunds, and cancellation
- Transition assistance if the relationship ends
The contract should reserve clinical judgment to the clinical entity and avoid giving a management company control over treatment decisions, clinical staffing, records, or patient care where state law reserves those functions to licensed professionals.
Does a white-label platform provide the medical director?
Some platforms supply clinicians through a contracted network, but that does not make the platform the legal medical practice or make a medical-director arrangement sufficient in every state. Ask who employs or contracts with clinicians, whether they evaluate and follow patients, and who controls protocols and quality decisions.
Is a white-label longevity program FDA-approved?
No. FDA approval does not apply to an ordinary branded program, platform, or business model merely because it uses approved medications, laboratory services, or clinical technology. Compounded drugs are not FDA-approved.
Who is responsible for prescribing?
The appropriately licensed clinician responsible for the patient’s care makes prescribing decisions. The platform may provide intake, scheduling, records, and communications infrastructure, but it should not automatically select treatment or direct a clinician to prescribe for a specific patient. Rules vary by state; for example, Texas has requirements for delegated prescriptive authority, while Massachusetts requires physician licensure for practicing medicine or prescribing.
Do I need a physician to run a longevity wellness platform?
Yes, once the platform provides medical care: diagnosis, clinical assessment, prescribing, and medical follow-up require appropriately licensed clinicians. A platform limited to general education does not provide medical care. The answer depends on services, claims, patient interactions, and states involved.
Does a longevity platform need a HIPAA business associate agreement?
Yes, if it handles protected health information for a covered healthcare provider as a business associate. HHS says covered entities engaging business associates must have a written contract requiring appropriate safeguards and applicable HIPAA obligations.
What should I review before launching?
- The offering is described as wellness, medical care, or both.
- The clinical entity and management company have distinct responsibilities.
- Clinician licensure is mapped to each patient state.
- Eligibility, prescribing, records, and escalation remain under clinical control.
- HIPAA roles and agreements are documented where applicable.
- Marketing claims match supporting evidence and the overall net impression.
- Compounded-drug language avoids FDA-approval, equivalence, and unsupported-results claims.
- Recurring-payment terms, consent, and cancellation workflows are clear.
- The vendor agreement identifies data, support, clinical, and transition responsibilities.
- A qualified reviewer has examined the structure before launch.
To review one infrastructure option, see the white-label longevity program. The objective is to use technology and administrative support while keeping business ownership and clinical authority clearly assigned.
Educational disclaimer: This article is for general business and educational purposes. It is not legal advice, medical advice, a diagnosis, or a recommendation to offer a particular service or medication. Telehealth, professional-entity, prescribing, privacy, advertising, and compounding requirements vary by state and may change. Obtain advice from qualified professionals for the proposed model.
Related reading: the full guide this article belongs to, Chiropractic Weight Management Program: How to Add One in 2026, Which GLP-1 Medications Should a Weight Loss Clinic Offer?.
Written and reviewed by MDLaunchr's clinical and compliance team. We build white-label telehealth infrastructure for founders, creators, and healthcare operators—covering providers, pharmacy, technology, and compliance.
This article is for general informational and educational purposes only and is not medical, legal, or regulatory advice. It does not create a provider-patient relationship and should not be used to diagnose or treat any condition. Telehealth and compounding regulations vary by state and change over time—consult qualified legal, clinical, and compliance professionals before launching or operating a telehealth program.
Frequently asked questions
What is a white-label longevity program?
A white-label longevity program provides branded technology and operational infrastructure for a healthy-aging business, often including intake, scheduling, messaging, payments, records workflows, and clinical coordination.
What does a white-label longevity telehealth platform include?
It may include a branded website or app, virtual-visit tools, intake and consent workflows, scheduling, payments, laboratory routing, analytics, customer support, and clinician coordination.
Does a white-label telehealth platform provide the medical director?
A platform may coordinate clinicians or a network, but a medical-director arrangement does not automatically establish a compliant medical practice or transfer clinical authority in every state.
Who is responsible for prescribing in a longevity program?
An appropriately licensed clinician responsible for the patient’s care makes prescribing decisions; the platform supplies administrative infrastructure rather than selecting treatment.
Can telehealth companies advertise compounded medications as FDA-approved?
No. FDA states that compounded drugs are not FDA-approved and should not be marketed as FDA-approved, generic equivalents, or clinically proven to produce the same results as approved products.
What claims can a longevity clinic legally make?
Claims should be truthful, not misleading, and supported by competent and reliable scientific evidence matching the exact service, product, population, and outcome represented.
Do I need a HIPAA business associate agreement for a telehealth platform?
A business associate agreement may be required when the platform handles protected health information for a covered healthcare provider as a business associate.
Is a white-label longevity program FDA-approved?
No. FDA approval does not apply to an ordinary branded program or platform, and compounded drugs should not be described as FDA-approved.
- Federal Trade Commission — Health Products Compliance GuidanceNegative Option RuleRestore Online Shoppers Confidence Act
- U.S. Food & Drug Administration — FDA Telehealth Companies What Know When Promoting Compounded DrugsCompounding and FDA Questions and Answers
- California State Government — TelehealthPractice Information
- Massachusetts State Government — Board of Registration in Medicine Approves Policy on TelemedicineMedical Spa Services Advisory
- HHS Telehealth — Legal Considerations
- U.S. Department of Health & Human Services — Covered Entities
- Texas State Government — Prescribing and Supervision